Niva Bupa Health Insurance Company Ltd. (formerly known as Max Bupa Health Insurance Company Limited) is a joint venture between the Bupa Group and Fettle Tone LLP. Bupa, a UK-based healthcare services expert, has seven decades of experience in the healthcare industry and serves a customer base of 50 million in over 190 countries. Fettle Tone LLP is an entity controlled and managed by True North, one of India’s largest domestic private equity funds.
Niva Bupa Health Insurance Company, an Book Built Issue amounting to ₹2,200.00 Crores, consisting an Fresh Issue of 1,081.08 Lakh Shares worth ₹800.00 Crores and an Offer for Sale of 1,891.89 Lakh Shares totalling to ₹14,00.00 Crores. The subscription period for the Niva Bupa Health Insurance Company IPO opens on November 07, 2024, and closes on November 11, 2024. The allotment is expected to be finalized on or about Tuesday, November 12, 2024, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Thursday, November 14, 2024.
The Share price band of Niva Bupa Health Insurance Company IPO is set at ₹70 to ₹74 per equity share. The Market Capitalisation of the Niva Bupa Health Insurance Company Limited at IPO price of ₹74 per equity share will be ₹13,519.99 Crores. The lot size of the IPO is 200 shares. Retail investors are required to invest a minimum of ₹14,800, while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (2,800 shares), amounting to ₹2,07,200.
Morgan Stanley India Company Private Limited, ICICI Securities Limited, Axis Capital Limited, Kotak Mahindra Capital Company Limited, HDFC Bank Limited and Motilal Oswal Investment Advisors Limited are the book-running lead manager while KFin Technologies Limited is the registrar for the Issue.
Niva Bupa Health Insurance Company Limited IPO GMP Today
The Grey Market Premium of Niva Bupa Health Insurance Company Limited IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.
Niva Bupa Health Insurance Company Limited IPO Live Subscription Status Today: Real-Time Updates
As of 07:00 PM on 11 November 2024, the Niva Bupa Health Insurance Company IPO live subscription status shows that the IPO subscribed 1.80 times on its Final day of subscription period. Check the Niva Bupa Health Insurance Company IPO Live Subscription Status today at BSE.
Niva Bupa Health Insurance Company IPO Anchor Investors Report
Niva Bupa Health Insurance Company has raised ₹989.99 Crores from Anchor Investors at a price of ₹289 per shares in consultation of the Book Running Lead Managers. The company allocated 13,37,83,783 equity shares to the Anchor Investors. Check Full List of Niva Bupa Health Insurance Company Anchor Investor List.
Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion.
Niva Bupa Health Insurance Company Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Niva Bupa Health Insurance Company IPO allotment date is 12 November, 2024, Tuesday. Niva Bupa Health Insurance Company IPO Allotment will be out on 12th November 2024 and will be live on Registrar Website from the allotment date. Check Niva Bupa Health Insurance Company IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Niva Bupa Health Insurance Company Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.
Objectives of Niva Bupa Health Insurance Company Limited IPO
Niva Bupa Health Insurance Company Issue Proceeds from the Fresh Issue will be utilized towards the following objects :
1. Augmentation of capital base to maintain and strengthen solvency levels
2. General corporate purposes
Refer to Niva Bupa Health Insurance Company Limited RHP for more details about the Company.
Check latest IPO Review & analysis, Live IPO GMP today, Live IPO Subscription Status Today, Share Price, Financial Information and other details before applying in the IPO.
The Upcoming IPOs in this week and coming weeks are Archit Nuwood Industries Limited, Swiggy, ACME Solar Holdings, Neelam Lines and Garments, Niva Bupa Health, Rosmerta Digital, NTPC Green, Avanse Financial.
Current active IPO is Sagility India Limited.
The Closed IPOs are Afcons Infrastructure Limited IPO, Usha Financial Services Limited IPO, Godavari Biorefineries Limited IPO, Usha Financial Services Limited IPO, United Heat Transfer Limited IPO, OBSC Perfection Limited IPO, Danish Power Limited IPO.
The Recently Listed IPOs which is available for trading in stock Market are Waaree Energies Limited IPO, Deepak Builders & Engineers India Limited IPO, Premium Plast Limited IPO, Shiv Texchem Limited IPO, Garuda Construction and Engineering Limited IPO, Khyati Global Ventures Limited IPO, Paramount Dye Tec Limited IPO, Subam Papers Limited IPO, Neopolitan Pizza and Foods Limited IPO, HVAX Technologies Limited IPO, Saj Hotels Limited IPO, Forge Auto International Limited IPO, Nexxus Petro Industries Limited IPO, Diffusion Engineers Limited IPO, Saharsa Electronic Solutions Limited IPO, Thinking Hats Entertainment Solutions Limited IPO, Unilex Colours and Chemicals Limited IPO and many more.
Niva Bupa Health Insurance Company IPO Details |
|||||||||||
IPO Date | November 07, 2024 to November 11, 2024 | ||||||||||
Listing Date | November 14, 2024 | ||||||||||
Face Value | ₹10 | ||||||||||
Price | ₹70 to ₹74 per share | ||||||||||
Lot Size | 200 Equity Shares | ||||||||||
Total Issue Size | 29,72,97,297 Equity Shares (aggregating up to ₹2,200.00 Cr) | ||||||||||
Fresh Issue | 10,81,08,108 Equity Shares (aggregating up to ₹800.00 Cr) | ||||||||||
Offer for Sale | 18,91,89,189 Equity Shares (aggregating up to ₹14,00.00 Cr) | ||||||||||
Issue Type | Book Built Issue | ||||||||||
Listing At | BSE & NSE | ||||||||||
Share holding pre issue | 1,71,89,18,290 | ||||||||||
Share holding post issue | 1,82,70,26,398 |
Niva Bupa Health Insurance Company IPO Lot Size |
|||||||||||
Application | Lots | Shares | Amount | ||||||||
Retail (Min) | 1 | 200 | ₹14,800 | ||||||||
Retail (Max) | 13 | 2,600 | ₹1,92,400 | ||||||||
S-HNI (Min) | 14 | 2,800 | ₹2,07,200 | ||||||||
S-HNI (Max) | 67 | 13,400 | ₹9,91,600 | ||||||||
B-HNI (Min) | 68 | 13,600 | ₹10,06,400 |
Niva Bupa Health Insurance Company IPO Timeline (Tentative Schedule) |
|||||||||||
IPO Open Date | Thursday, November 7, 2024 | ||||||||||
IPO Close Date | Monday, November 11, 2024 | ||||||||||
Basis of Allotment | Tuesday, November 12, 2024 | ||||||||||
Initiation of Refunds | Wednesday, November 13, 2024 | ||||||||||
Credit of Shares to Demat | Wednesday, November 13, 2024 | ||||||||||
Listing Date | Thursday, November 14, 2024 | ||||||||||
Cut-off time for UPI mandate confirmation | 5 PM on November 11, 2024 |
Niva Bupa Health Insurance Company IPO Reservation |
|||||||||||
Investor Category | Shares Offered | Reservation % | |||||||||
QIB Portion | 8,91,89,189 | Not Less than 75% of the Issue | |||||||||
Non-Institutional Investor Portion | 4,45,94,594 | Not More than 15% of the Issue | |||||||||
Retail Shares Offered | 2,97,29,729 | Not More than 10% of the Issue |
Niva Bupa Health Insurance Company IPO Promoter Holding |
|||||||||||
Share Holding Pre Issue | 88.99% | ||||||||||
Share Holding Post Issue | % |
Niva Bupa Health Insurance Company IPO Subscription Status |
|||||||||||
Investor Category | Shares Offered | Shares Bid For | No oF Times Subscribed | ||||||||
Qualified Institutional Buyers (QIB) | 9,42,85,715 | 19,38,48,200 | 2.06 | ||||||||
Non Institutional Investors(NIIS) | 4,71,42,857 | 3,18,22,400 | 0.68 | ||||||||
Retail Individual Investors (RIIs) | 3,14,28,571 | 8,57,02,600 | 2.73 | ||||||||
Total | 17,28,57,143 | 31,13,73,200 | 1.80 |
Niva Bupa Health Insurance Company's purpose is to “give every Indian the confidence to access the best healthcare”. They aim to achieve this purpose through
their health insurance products and services that enable customers to navigate their healthcare journey, by providing them
access to a holistic health ecosystem. They are one of India’s largest and fastest growing
SAHI based on overall health GDPI of ₹54,944.28 million in Fiscal 2024. They had a market share in the Indian SAHI market of 17.29%,
16.24%, 15.58% and 13.87% for year-to-date August 2024 (Fiscal 2025), Fiscals 2024, 2023, and 2022 respectively based on retail health GDPI.
Responding to the evolving needs of the customers over 16 years of operations, they have built a track record of product
innovation catering to a range of customer groups. They offer the customers the ability to access a comprehensive health ecosystem and service capabilities via their ‘Niva
Bupa Health’ mobile application and website, thereby offering them a holistic proposition. They had 14.99 million active lives insured as of June 30, 2024. They are strategically focused on the retail health market and
their GWP from their retail health products was 67.65% and 68.47% of their overall GWP for the three months ended June 30,
2024 and Fiscal 2024, respectively. In India, health insurance providers can be broadly
categorized into three main types and as of August 31, 2024 there are four IRDAI-recognized public insurers excluding
specialized insurers, 21 private insurers, and 7 IRDAI-recognized SAHIs.
The Company have a telemarketing sales team, comprising 412 employees as of June 30, 2024. The Banker of the Niva Bupa Health Insurance Company Limited is Axis Bank Limited.
India’s health insurance
Non-life insurance includes motor, health, travel, fire, marine, and other segments such as microinsurance.
Historically, motor insurance has held a dominant position, representing 39.3% of the non-life GDPI in FY18.
However, over the past five years, health insurance has experienced substantial growth, expanding its GDPI share
from 24.6% in FY18 to 37.1% in FY24. Health insurance has exhibited the highest growth with a CAGR of 19.5%
between FY18 and FY24, surpassing the overall non-life insurance market’s growth (CAGR of 11.5%) over the
same period. Health insurance is expected to maintain its consistent growth, projected to increase at a CAGR of 15-
17% from FY24 to FY29.
Health insurance has witnessed growth owing to increasing awareness of insurance as protection against healthcare
inflation, rise in the number of diseases and increasing affordability with customized health insurance products
provided by specialized players. Other factors which may affect the performance of health insurance industry
include:
• India’s real GDP growth rate which is expected to grow at a CAGR of 6.5% from CY2024 to CY2029, the
highest among the top 10 economies;
• Significantly lower insurance penetration when compared to developed global economies in CY2023;
• India’s health expenditure as a percentage of GDP amongst the lowest globally in CY2021;
• High out-of-pocket medical expenses;
• Rising disease burden in India, leading to increased healthcare expenses on diagnosis, treatment and posttreatment care, which, along with an increase in public awareness of these health risks, is expected to lead
to a higher demand for health insurance; and
• Growing digitalization.
India’s health insurance sector has witnessed rapid growth since FY18. The health insurance GDPI has more than
doubled from INR 0.37 Tn (USD 4.5 Bn) in FY18 to INR 1.08 Tn (USD 13.0 Bn) in FY24, growing at a CAGR of
19.5%. As per Redseer estimates, total health GDPI is expected to reach INR 2.2-2.4 Tn (USD 26-28 Bn) by FY29.
As of FY24, Group health insurance (which provides coverage to a group of individuals, typically employees of
company) and Retail health insurance (which offers individual policies purchased directly by individuals or families
from insurance companies) businesses represent approximately 90% of the overall health insurance GDPI. Retail
health insurance contributed approximately 39% of overall health insurance GDPI in FY24. As per Redseer
estimates, Retail business is expected to grow at a CAGR of 18-21% over the next 5 years and GDPI will reach INR
1.0-1.1 Tn (USD 12-13 Bn) by FY29.
Group health insurance GDPI is expected to grow at a rate of 13-16% over the next 5 years (from FY24 to FY29),
driven by an increase in the number of enterprises, and expanding adoption among Small and Medium-sized
Enterprises (“SMEs”). With near 100% adoption among large enterprises, insurers are increasingly focusing on
SMEs to drive Group health growth. SMEs represent a potentially higher profitability business compared to large
enterprises. The reasons for higher profitability include:
• Large corporates tend to offer health policies covering both employees and their parents. On the other
hand, SMEs typically buy employee only policies. Consequently, insurers receive a lot more claims from large corporates due to age-related risks.
• Insurers also have a higher control on managing risk in SMEs. This is because SMEs often have simpler
organizational structures and operations, and a smaller pool of employees compared to corporates which
translates to fewer data points for insurers to analyse. Insurers can also directly engage with SME owners
and managers, allowing for better understanding of their businesses and risk exposures. This leads to a
higher potential for cost efficiency for insurers.
Thus, underwriting SMEs tend to be more profitable as compared to underwriting large corporates due to better
access to customer pool data which facilities the ability to better price risks.
Furthermore, Group health insurance products are increasingly being sold as affinity products, where they are
bundled with other products and solutions and marketed as comprehensive products. By bundling Group health
insurance with market solutions, insurers can customize coverage options and benefits to align more closely with
the specific needs of customers, thereby enabling targeted sales. Thus, these products adopt characteristics like
Retail health insurance offerings. This approach not only enhances the attractiveness of the insurance offering but
also allows insurers to leverage the marketing and distribution channels of their partners.
The Group health insurance market in India has seen significant expansion and increased at a CAGR of 20.21%
from Fiscal 2018 to Fiscal 2024, outpacing the retail health insurance sector’s growth rate of 17.75% during the
same period. The group health insurance market in India has seen significant growth, increasing from INR 0.21
trillion (USD 2.55 Bn) in FY18 to INR 0.66 trillion (USD 7.90 Bn) in FY24. The group health insurance GDPI in
India Aug’FY25 stands at INR 0.31 billion (USD 3.70 Bn).
The growth of group health insurance in India is driven by multiple factors. Regulatory support and initiatives like
Ayushman Bharat Yojana have expanded coverage adoption, while tax incentives make it financially advantageous
for employers. Corporates are increasingly recognizing the importance of health insurance for attracting and
retaining talent. Furthermore, the development of innovative products for small SMEs, covering even four
employees, further boosts gross premiums. Additionally, an expanding workforce, increasing healthcare awareness,
and urbanization are promoting the growth of group health insurance.
Retail health insurance currently accounts for ~39% of the overall health insurance for FY24, having grown at a
CAGR of 17.7% between FY18 and FY24. Going forward, it is expected to grow at a CAGR of 18-21% over the next 5 years to reach approximately INR 1.0-1.1 Tn (USD 12-13 Bn) by FY29. The retail health insurance segment
is the most promising segment in the health insurance industry in India as of March 31, 2024, due to higher average
premium per life, higher renewal rates and lower Combined Ratios as compared to group health insurance.
Lives insured under Retail health insurance increased from 33.3 Mn to 52.9 Mn between FY18 to FY23. It is
expected to grow at a CAGR of 10-12% from FY23 to FY29 to reach 90-100 Mn lives by FY29. Retail health
insurance is also subject to seasonal fluctuations in product mix, operating results, and cash flow The sale of retail
health insurance products increases in the last quarter of each fiscal year to take advantage of income tax benefits
available to customers.
Retail health insurance has witnessed an increase in average premium paid per life from INR 4,758 in FY18 (USD
57.3) to INR 6,700 (USD 80.7) in FY23 and has consistently remained higher than Group business (including
Government) whose average premium per life has increased from INR 472 (USD 5.7) in FY18 to INR 1091 (USD
13.2) in FY23. The higher average premium per life in Retail health insurance premiums can be attributed to the
expansion of coverage options and the introduction of innovative & additional features in product offerings such as
wellness programs, telemedicine services, and coverage for specific critical illnesses. These added features enhance
the overall value proposition of Retail health insurance and justify the higher premiums, as policyholders recognize
the comprehensive protection and additional perks that come with the plans.
Health Insurers (SAHI) landscape in India
In India, health insurance providers can be broadly categorized into three main types: Private Insurers, Public
Insurers, and Standalone Health Insurers (“SAHI”). Public insurers include government-owned health and non-life
insurers, Private insurers are privately-owned entities offering health and non-life insurance services, while SAHIs
are specialized entities focused on health insurance (incl. travel and personal accident) coverage only. As of August
31, 2024 there are four IRDAI-recognized public insurers excluding specialized insurers, twenty-one private
insurers and seven IRDAI-recognized SAHI companies in India: (1) Aditya Birla Health Insurance, (2) Care Health
Insurance, (3) Manipal Cigna Health Insurance, (4) Niva Bupa Health Insurance, (5) Star Health & Allied
Insurance, (6) Narayana Health Insurance, and (7) Galaxy Health Insurance. These SAHIs, Private and Public
insurers form the competitive landscape of the health insurance industry.
The competitive landscape of health insurance in India is based on several factors including brand recognition and
the reputation of the provider of products and services, customer satisfaction, underwriting and pricing of risks,
distribution network and access to services and service personnel, pricing and quality of services, product design
and diversification, financial strength, high-quality and stable professional team and information technology
capabilities.
SAHIs lead Retail health insurance with 56% market share in FY24 while Public insurers dominate the Government
health insurance with 68% market share. As of FY24, Public insurers hold a 46% market share in Group health
insurance, while Private insurers and SAHIs account for 39% and 16% respectively.
SAHIs have a better Loss and Combined ratio as compared to Private and Public insurers. The Claims ratio for
SAHIs was 65% in FY24, whereas Private and Public Insurers had a Claims ratio of 90% and 103% respectively.
This can be attributed to the large share of Retail insurance for SAHIs as Retail tends to have a lower claims ratio in
comparison to Group insurance. Health insurance and Non-life insurance players across the industry were impacted
by higher claims driven by second COVID-19 wave in Fiscal 2022, which had led to an increased claims ratio in
that year.
SAHIs have an Expense ratio of 35% in FY24 as compared to 26% and 21% of Private and Public insurers
respectively and have consistently shown a constant Expense ratio from FY22 to FY24. This is largely due to the
greater reliance of SAHIs on Individual Agents for their Retail business distribution. Taking into consideration both
Loss and Expense ratios, the Combined ratios for Private and Public insurers in FY24 stand at 116% and 125%
respectively. In comparison, SAHIs have the lowest Combined ratio of 100% in the same year, yielding better
financial results than Private and Public insurers.
SAHIs GDPI has already quadrupled in last 6 years and is expected to reach INR 0.7-0.9 Tn (USD 8.7-10.6 Bn)
growing at a CAGR of 25-30% from FY24 to FY29. Their focus on health products allows for innovation and a
wider range of offerings. Additionally, increased focus on tier II+ markets (cities/areas with population below 2
million), tie-ups with new Banca partners and stronger emphasis on digital sales will further add to the growth.
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED COMPETITIVE STRENGTHS
1. Granular retail health insurer with a focus on delivering robust GWP growth, capital efficiency and profitability
2. Their customer centric proposition driving customer experience and retention
3. Technology-led automated approach to customer servicing
4. Bupa parentage and brand associated with health insurance and healthcare
5. Their Domain Knowledge and Experience in Claims and Provider Management
6. Multi-Channel Diversified Pan-India Distribution, with Technology-Led Empowerment of Distribution Partners
7. Their Technology and Analytics Platforms
8. Experienced Management Team Backed by Established Investors and Underpinned by Sustainable Employment
Practices
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED STRATEGIES
1. Continuing to grow their product portfolio to serve the needs of customers, expand their partnerships with Network
Hospitals, and further develop their healthcare ecosystem
2. Continue to invest in technology and analytics to facilitate the sales and servicing of their products
3. Further expand their presence in existing geographies within India, invest in deepening their distribution channels and
increase market share in retail health insurance
4. Continue to invest in talent recruitment, development and retention to drive execution
5. Deepen culture of sustainability and “doing the right thing” to create a sustainable health franchise for future
generations
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED RISK FACTORS & CONCERNS
1. The profitability depends on their ability to manage their underwriting risks and appropriately price their products.
2. A significant portion of the business is generated from the health insurance line of business.
3. They are dependent on their intermediated distribution channels, particularly individual agents, corporate agents
and brokers.
4. They may be unable to obtain reinsurance on a timely basis at reasonable costs and could be exposed to credit risks
in their reinsurance contracts, including with General Insurance Corporation of India (“GIC Re”).
Period Ended | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
---|---|---|---|
Reserve of Surplus | 12,820.22 | 3,342.64 | 1,254.02 |
Total Assets | 61,918.69 | 38,765.65 | 27,384.35 |
Total Borrowings | 2,500.00 | 2,500.00 | 2,500.00 |
Fixed Assets | 588.12 | 555.82 | 496.78 |
Cash | 1,428.17 | 1,018.60 | 588.13 |
Net Borrowing | 1,071.83 | 1,481.40 | 1,911.87 |
Revenue | 41,186.31 | 28,592.35 | 18,845.42 |
EBITDA | 1,379.95 | 712.82 | -1,632.37 |
PAT | 818.52 | 125.4 | -1965.25 |
EPS | 0.51 | 0.09 | -1.42 |
Note 1:- RoE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Other comprehensive income/ (loss) for the period/year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in Newspaper Advertisement.
Key Performance Indicator |
|||||||||||
KPI | Values | ||||||||||
EPS Pre IPO (Rs.) | ₹0.51 | ||||||||||
EPS Post IPO (Rs.) | ₹0.45 | ||||||||||
P/E Pre IPO | 145.09 | ||||||||||
P/E Post IPO | 164.44 | ||||||||||
ROE | 5.68% | ||||||||||
ROCE | % | ||||||||||
P/BV | 4.72 | ||||||||||
Debt/Equity | 0.12 | ||||||||||
RoNW | 5.68% |
Niva Bupa Health Insurance Company Limited IPO Peer Comparison |
|||||||||||
Company Name | EPS | ROCE | ROE | P/E (x) | P/Bv | Debt/Equity | RoNW (%) | ||||
Niva Bupa Health Insurance Company Limited | ₹0.45 | % | 5.68% | 164.44 | 4.72 | 0.12 | 5.68% | ||||
Star Health and Allied Insurance Company Limited | ₹14.7 | 17.7% | 14.3% | 32.8 | 4.03 | 0.07 | 14.3% | ||||
ICICI Lombard General Insurance Company Limited | ₹45.1 | 22.5% | 17.0% | 42.5 | 6.94 | 0.00 | 17.0% | ||||
The New India Assurance Company Limited | ₹8.26 | 0.56% | 1.19% | 22.4 | 1.00 | 0.00 | 1.19% |
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED
C-98, 1st Floor, Lajpat
Nagar, Part 1, South Delhi,
New Delhi – 110 024,
Delhi, India
Contact Person : Rajat Sharma
Telephone : +91 124 635 4900
Email ID : Investor@nivabupa.com
Website : www.nivabupa.com
Registrar : KFin Technologies Limited
Contact Person : M Murali Krishna
Telephone : +91 40 6716 2222
Email ID : nivabupa.ipo@kfintech.com
Website : https://www.kfintech.com/
Lead Manager :
ICICI Securities Limited
Kotak Mahindra Capital Company Limited
Axis Capital Limited
Morgan Stanley India Company PrivateLimited
HDFC Bank Limited
Motilal Oswal Investment Advisors Limited
Niva Bupa Health Insurance Company Ltd. (formerly known as Max Bupa Health Insurance Company Limited) is a joint venture between the Bupa Group and Fettle Tone LLP. Bupa, a UK-based healthcare services expert, has seven decades of experience in the healthcare industry and serves a customer base of 50 million in over 190 countries. Fettle Tone LLP is an entity controlled and managed by True North, one of India’s largest domestic private equity funds.
The Revenues from operations for the Fiscals 2024, 2023 and 2022 were ₹41,186.31 Million, ₹28,592.35 Million and ₹18,845.42 Million, respectively. The EBITDA for the Fiscals 2024, 2023 and 2022 were ₹1,379.95 Million, ₹712.82 Million and ₹-1,632.37 Million, respectively. The Profit after Tax for the Fiscals 2024, 2023 and 2022 was ₹818.52 Million, ₹125.4 Million and ₹-1965.25 Million, respectively.
For the Niva Bupa Health Insurance Company IPO, the company is issuing shares at a pre-issue EPS of ₹0.51 and a post-issue EPS of ₹0.45. The pre-issue P/E ratio is 145.09x, while the post-issue P/E ratio is 164.44x against the Industry P/E ratio is 38.60x. The company's RoE for FY24 is 5.68%. These metrics suggest that the IPO is fully priced.
The Grey Market Premium (GMP) of Niva Bupa Health Insurance Company showing potential listing gains of 0%. Given the company's financial performance and the valuation of the IPO, we recommend Investors to Avoid to the Niva Bupa Health Insurance Company Limited IPO for Listing gain or long term investment purposes.
Disclaimer: The information provided in this IPO review is for educational and informational purposes only and should not be construed as financial advice or an offer to buy or sell securities. The review must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. The content is based on publicly available information and market perceptions as of the date of publication and is subject to change. Neither the author nor the website is responsible for any losses or damages arising from the use of this information.
About the Author
CA Abhay Kumar (Also known as CA Abhay Varn) is a qualified Chartered Accountant by profession and cleared CA at age 21. He is a SEBI Registered Research Analyst with Registration Number - INH300008465. He Possesses 8+ years of experience in the Stock Market Field and has also worked in Big CA firms during the training period. He is good at Technical analysis and Fundamental Analysis and uses both Technical and Fundamental analysis along with five other important factors that affect the movement of the Market namely Global Market Analysis, Upcoming Event Analysis, Institutional Money Analysis, Derivative Data Analysis, and Emotions and Sentiment of Traders and Investors in his Framework called - Technical Fundamental GUIDE to find the winning Trades.
You can connect with the Author on Telegram, YouTube and Website.
FNO Stocks with CA Abhay
Stock Market Masterclass
Equity Trading with CA Abhay
Option Trading with CA Abhay
Equity Investment with CA Abhay
FNO Stocks with CA Abhay
Equity Investment with CA Abhay
Option Trading with CA Abhay
Stock Market Masterclass
Equity Trading with CA Abhay
Copyright @2020 Design & Developed by Info Web Software